Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : SARS - what next? -- Ignore unavailable to you. Want to Upgrade?

To: Maurice Winn who wrote (801)	11/11/2003 7:28:30 PM
From: Henry Niman	Respond to of 1070

>>, I could buy shares in a company which is working on sars vaccines, then do some private DNA manipulations on sars bugs which would keep the public in fear and buying the company's vaccines. << Is there an approved HIV vaccine? SARS CoVs mutate quite a bit. Add selection pressure if vaccines and there will be stronger selection of mutations. There are about 3 mutations per replication cycle. Your private DNA manipulators wouldn't be able to keep up with natural selection.

To: Maurice Winn who wrote (801)	11/19/2003 2:13:52 PM
From: Henry Niman	Read Replies (1) \| Respond to of 1070

SARS may be back: chinapost.com.tw Kaohsiung reports suspected SARS case 2003/11/19 TAIPEI, Taiwan, The China Post Staff A Kaohsiung hospital yesterday reported this winter's first SARS (severe acute respiratory syndrome) case in Taiwan. Doctors at the Union Hospital said they diagnosed a resident of the southern Taiwan port city as a suspected SARS case. The resident, whose identity was withheld, visited the hospital in the afternoon.